ketamine has been researched along with Neurodevelopmental Disorders in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Infections during pregnancy are associated with an increased risk of neuropsychiatric disorders with developmental etiologies, such as schizophrenia and autism spectrum disorders (ASD)." | 1.91 | (R)-ketamine attenuates neurodevelopmental disease-related phenotypes in a mouse model of maternal immune activation. ( da Silva Júnior, JC; de Andrade Silva, SC; de Lima, DA; de Oliveira, EG; de Santana, JH; de Souza Barbosa, MV; Dos Santos Junior, OH; Duarte, FS; Gomes, DA; Lagranha, CJ; Lira, EC, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Oliveira, EG | 1 |
| de Lima, DA | 1 |
| da Silva Júnior, JC | 1 |
| de Souza Barbosa, MV | 1 |
| de Andrade Silva, SC | 1 |
| de Santana, JH | 1 |
| Dos Santos Junior, OH | 1 |
| Lira, EC | 1 |
| Lagranha, CJ | 1 |
| Duarte, FS | 1 |
| Gomes, DA | 1 |
| B Hughes, R | 1 |
| Whittingham-Dowd, J | 1 |
| Simmons, RE | 1 |
| Clapcote, SJ | 1 |
| Broughton, SJ | 1 |
| Dawson, N | 1 |
2 other studies available for ketamine and Neurodevelopmental Disorders
| Article | Year |
|---|---|
(R)-ketamine attenuates neurodevelopmental disease-related phenotypes in a mouse model of maternal immune activation.
Topics: Animals; Behavior, Animal; Cytokines; Disease Models, Animal; Female; Humans; Ketamine; Male; Mice; | 2023 |
Ketamine Restores Thalamic-Prefrontal Cortex Functional Connectivity in a Mouse Model of Neurodevelopmental Disorder-Associated 2p16.3 Deletion.
Topics: Animals; Calcium-Binding Proteins; Disease Models, Animal; Gene Deletion; Injections, Intraperitonea | 2020 |